Glycopyrrolate Injection
Product Images NDC 16729-474

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 16729-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glycopyrrolate Structural Formula (Glycopyrrolate Injection 1)

Chemical structure diagram of glycopyrrolate, the active ingredient in Glycopyrrolate injection. The diagram shows the molecular arrangement with the bromide ion (Br-) as part of the compound.*

FDA Label Image

Glycopyrrolate Injection, Usp 4 mg/20 mL (0.2 mg/ml) 10 X 20 mL Multiple Dose Vials (Glycopyrrolate Injection 10)

Label for Glycopyrrolate Injection, USP, 4 mg/20 mL (0.2 mg/mL) multiple dose vial by Accord Healthcare, Inc. It indicates use for intramuscular or intravenous administration, contains benzyl alcohol preservative, and is not for use in newborns. Storage instructions and manufacturing details for Accord Healthcare and Intas Pharmaceuticals are also included.*

FDA Label Image

Glycopyrrolate Injection 11

Glycopyrrolate Injection, USP 0.2 mg/mL (4 mg/20 mL) label for injectable solution in multiple dose vials. Manufactured by Intas Pharmaceuticals for Accord Healthcare, Inc., the label indicates usage for intramuscular or intravenous administration and contains benzyl alcohol as a preservative. The package contains 10 vials of 20 mL each. The label includes storage instructions and warnings not to use in newborns.*

FDA Label Image

Glycopyrrolate Injection, Usp 0.2 mg/ml 1 mL Single Dose Vial (Glycopyrrolate Injection 2)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL by Accord Healthcare, Inc. The label indicates it contains benzyl alcohol and is for intramuscular or intravenous administration. It is a 1 mL single dose vial. The label includes NDC 16729-471-63 and states prescription use only.*

FDA Label Image

Glycopyrrolate Injection, Usp 0.2 mg/ml 25 X 1 mL Single Dose Vials (Glycopyrrolate Injection 3)

Label for Glycopyrrolate Injection USP, 0.2 mg/mL, in a 1 mL single-dose vial. The label states the product contains benzyl alcohol and is for intramuscular or intravenous use. It is manufactured for Accord Healthcare, Inc., Durham, NC, USA. The label also includes a barcode and batch coding instructions.*

FDA Label Image

Glycopyrrolate Injection, Usp 0.4 mg/2 mL (0.2 mg/ml) 2 mL Single Dose Vial (Glycopyrrolate Injection 4)

Box label for Glycopyrrolate Injection, USP 0.2 mg/mL, a human prescription drug for intramuscular or intravenous administration. The label shows that it contains 25 single-dose 1 mL vials and is manufactured for Accord Healthcare, Inc. The label notes it contains benzyl alcohol and is not for use in newborns.*

FDA Label Image

Glycopyrrolate Injection, Usp 0.4 mg/2 mL (0.2 mg/ml) 25 X 2 mL Single Dose Vials (Glycopyrrolate Injection 5)

Label for Glycopyrrolate Injection USP 0.4 mg/2 mL (0.2 mg/mL) single dose vial. The product contains benzyl alcohol and is indicated for intramuscular or intravenous administration. Labeler is Accord Healthcare, Inc. The label includes NDC 16729-472-30 and barcode details.*

FDA Label Image

Glycopyrrolate Injection, Usp 1 mg/5 mL (0.2 mg/ml) 5 mL Multiple Dose Vial (Glycopyrrolate Injection 6)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) single-dose vial containing benzyl alcohol. Intended for intramuscular or intravenous administration. The label includes storage instructions and manufacturer details for Accord Healthcare, Inc.*

FDA Label Image

Glycopyrrolate Injection, Usp 1 mg/5 mL (0.2 mg/ml) 10 X 5 mL Multiple Dose Vials (Glycopyrrolate Injection 7)

Packaging label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) by Accord Healthcare, Inc. The label indicates intramuscular or intravenous administration, contains benzyl alcohol, and states 'Not For Use In Newborns.' The pack contains 25 single-dose vials of 2 mL each and includes storage information and manufacturing details.*

FDA Label Image

Glycopyrrolate Injection, Usp 4 mg/20 mL (0.2 mg/ml) 20 mL Multiple Dose Vial-label (Glycopyrrolate Injection 8)

Label for Glycopyrrolate Injection USP, 0.2 mg/mL strength, in a 5 mL multiple dose vial by Accord Healthcare, Inc. The label indicates it is for intramuscular or intravenous administration and contains benzyl alcohol. Storage and dosage instructions are partially visible, along with manufacturing information and a barcode.*

FDA Label Image

Glycopyrrolate Injection, Usp 4 mg/20 mL (0.2 mg/ml) 20 mL Multiple Dose Vial-mono Carton (Glycopyrrolate Injection 9)

Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) vial label by Accord Healthcare, Inc. The label includes warnings such as 'NOT FOR USE IN NEWBORNS' and indicates the presence of benzyl alcohol. It is intended for intramuscular or intravenous administration and comes in 10 x 5 mL multiple dose vials. Storage instructions specify keeping at 20°C to 25°C. Manufactured by Accord Healthcare, Inc., Durham, NC, and Intas Pharmaceuticals Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.